Novartis could cut around 130 jobs in Switzerland
Novartis could cut around 130 jobs in Switzerland ZURICH, Sept 2 (Reuters) - Novartis NOVN.S could cut around 130 jobs in Switzerland as it scales back some output at its home city of Basel, the Swiss drug maker said on Wednesday.
As part of a planned relocation out of Kleinbasel, an area of Basel, Novartis is set to stop small-scale production of biologics in the district by the end of 2027.
(Reporting by Marleen Kaesebier
Editing by Dave Graham)
Recent news on Novartis AG
See all newsNovartis' breast cancer drug cuts risk of death by 19% after six years, data shows
Novartis AG expected to post earnings of $2.27 a share - Earnings Preview
AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination (updated)
AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination
Brief: Novartis Receives European Commission Approval For Cosentyx